Skip to main content

Table 4 Evolution of biological parameters in the two groups

From: Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa

  DP AL
  D1 D4 D1-D4 p* D1 D4 D1-D4 p*
AST (IU/l)
(SD)
26.48
(15.17)
24.79
(12.10)
1.70
(17.51)
0.190 29.62
(26.14)
38.24
(131.0)
- 8.63
(132.6)
0.389
ALT (IU/l)
(SD)
18.91
(12.71)
19.73
(12.91)
- 0.82
(13.77)
0.418 24.20
(37.46)
34.19
(138.47)
- 9.99
(140.5)
0.347
Creatinin (mg/l)
(SD)
6.81
(2.46)
6.70
(2.41)
0.11
(1.52)
0.317 6.86
(2.45)
6.51
(2.51)
0.35
(1.9)
0.001
Bilirubin (mg/l)
(SD)
10.49
(7.39)
6.31
(2.99)
4.18
(7.42)
< 0.001 11.19
(8.51)
6.27
(3.30)
4.92
(8.57)
< 0.001
Haemoglobin (g/dl)
(SD)
10.80
(2.07)
10.66
(2.18)
0.14
(1.56)
0.221 10.75
(2.07)
10.39
(2.08)
0.36
(1.48)
0.001
  1. *paired t test